Effects of melittin, an amphipathic polypeptide, on various species of protL,n kinases were investigated. It was found that melittin inhibited the newly identified phospholipid-sensitive Ca2+-dependent protein kinase (from heart, brain, spleen and neutrophils) and the cardiac myosin light-chain kinase, a calmodulin-sensitive Ca2+-dependent enzyme. In contrast, melittin had little or no effect on either the holoenzymes of the cardiac cyclic AMP-dependent and cyclic GMP-dependent protein kinases or the catalytic subunit of the former. Kinetic analysis indicated that melittin inhibited phospholipid-sensitive Ca2+-dependent protein kinase non-competitively with (Ki = 1.9,UM), and competitively with respect to calmodulin (K, = 0.08,M); although exhibiting complex kinetics, its inhibition of the enzyme was reversed by myosin light chains (substrate protein). The present findings indicate the presence of functionally important hydrophobic or hydrophilic loci on the Ca2+-dependent protein kinases, but not on the cyclic nucleotide-dependent class of protein kinase, with which melittin can interact. Moreover, the kinetic data suggest that melittin inhibited myosin light-chain kinase by interacting with a site on the enzyme the same as, or proximal to, the calmodulin-binding site, thus interfering with the formation of active enzymecalmodulin-Ca2+ complex. 
exhibiting complex kinetics, its inhibition of the enzyme was reversed by myosin light chains (substrate protein). The present findings indicate the presence of functionally important hydrophobic or hydrophilic loci on the Ca2+-dependent protein kinases, but not on the cyclic nucleotide-dependent class of protein kinase, with which melittin can interact. Moreover, the kinetic data suggest that melittin inhibited myosin light-chain kinase by interacting with a site on the enzyme the same as, or proximal to, the calmodulin-binding site, thus interfering with the formation of active enzymecalmodulin-Ca2+ complex. 217 Melittin, a lytic polypeptide of 26 amino acids, is the primary organic component of bee venom (for a review, see Habermann, 1972) . Melittin exerts its effects, via the hydrophobic part of the molecule, by interacting with phospholipids in membranes or activating phospholipase A2 (another major component of dry bee venom), or both, leading to altered properties of membranes and activities of membrane-associated enzymes (Repke & Portius, 1963; Sessa et al., 1969; Vogt et al., 1970; Habermann, 1972; Mollay & Kreil, 1973 , 1974 Mollay et al., 1976; Ladd & Shier, 1979; Gelehrter & Rozengurt, 1980; Georghiou et al., 1981) . The toxic manifestations of bee venom on many tissues, however, are most likely due to the combined actions of melittin and phospholipase A2. Vol. 202 Myosin light-chain kinase is a calmodulin-sensitive Ca2+-dependent protein kinase. The mechanism of activation of this enzyme, and of other enzymes (such as phosphodiesterase) also stimulated by calmodulin and Ca2+, has been suggested to involve interactions of hydrophobic regions of the enzymes with a hydrophobic region of calmodulin, a Ca2+-binding protein (Klee et al., 1980; Weiss & Wallace, 1980) . A new species of Ca2+-dependent protein kinase that requires phospholipid (such as phosphatidylserine) instead of calmodulin as a cofactor has been reported (Takai et al., 1979; Kuo et al., 1980; Mori et al., 1980; Wrenn et al., 1980) . Although the mechanism by which phospholipid activates this enzyme is unclear, it is likely that a functionally important hydro-0306-3283/82/010217-08$01.50/1 ©) 1982 The Biochemical Society phobic region may be present on the enzyme, with which the phospholipid cofactor can interact. It is possible that melittin may potentially regulate activities of myosin light-chain kinase and phospholipid-sensitive Ca2+-dependent protein kinase. In the present paper we report the findings regarding inhibition by melittin of these two species of Ca2+-dependent protein kinases, and possible inhibitory mechanism of the surface-active toxin.
Experimental

Materials
Melittin (from bee venom, containing up to 20 units of phospholipase A/mg of solid), phospholipase A2 (from bee venom, 1500 units/mg of solid), lysine-rich histone (type III-S, histone HI), mixed histone (type II) and phosphatidylserine (from bovine brain) were from Sigma Chemical Co., St.
Louis, MO, U.S.A. The pure melittin (free of phospholipase A2 activity) was a gift from Dr. Gunther Kreil, Institute of Molecular Biology, Austrian Academy of Sciences, Vienna, Austria.
Methods
Phospholipid-sensitive Ca2+-dependent protein kinase was purified over 10000-fold (about 90% homogeneous) from the bovine heart extract by the steps of (NH4)2SO4 fractionation and DEAE-cellulose, controlled-pore glass, Sephacryl S-200 and phosphatidylserine-Affigel 102 chromatographies (B. C. Wise, R. L. Raynor & J. F. Kuo, unpublished work). The enzyme was also purified about 300-400-fold (20-30% homogeneous) from extracts of the pig spleen (R. C. Schatzman & J. F. Kuo, unpublished work) or the rat brain (R. S. Turner & J. F. Kuo, unpublished work) by the steps of DEAE-cellulose and Sephacryl S-200 chromatographies. Myosin light-chain kinase was purified to homogeneity from the bovine heart extract by the procedure essentially the same as that described by Walsh et al. (1979) . Homogeneous myosin light chains from the bovine heart were prepared by the method of Perrie & Perry (1970) , with modifications by Katoh et al. (1973) . Pure calmodulin was prepared from the pig brain extract by the fluphenazine affinity method of Charbonneau & Cormier (1979) . Cyclic AMP-dependent protein kinase (Kuo et al., 1970) and cyclic GMP-dependent protein kinase (Shoji et al., 1977) , both from the bovine heart extract, were partially purified as described elsewhere. The homogeneous catalytic subunit of bovine heart cyclic AMP-dependent protein kinase, prepared by the method of Bechtel et al. (1977) Post & Sen (1967) , and protein was determined by the method of Lowry et al. (1951) . Ca2+-EGTA buffers were prepared by the method of Pires & Perry (1977) .
Phospholipid-sensitive Ca2+-dependent protein kinase was assayed essentially as described by Kuo et al. (1980) AMP-dependent or cyclic GMP-dependent protein kinase, and the catalytic subunit of the former, was assayed as described previously (Kuo et al., 1970; Shoji et al., 1977) , in the incubation mixtures (0.2ml) containing 4Ogg of mixed histone and 0.5 uM cyclic nucleotides. Phosphorylated substrate proteins (histones or myosin light chains) were recovered by precipitating them from 5% trichloroacetic acid containing 0.25% tungstate.
Results
Melittin inhibited the cardiac phospholipid-sensitive Ca2+-dependent protein kinase in a concentration-related manner, without appreciably affecting its basal activity seen in the absence of CaCl2 (Fig. la) . The inhibition curves obtained for the commercial and pure preparation of melittin were superimposable, with a 50% inhibition seen at about 4pM (containing 0.05 units of phospholipase A2/ 0.2ml of incubation mixture using the commercial melittin) for both, indicating that the slight contamination by phospholipase A2 in the commercial melittin preparation (up to 20 units/mg of solid, or 60 units/,umol) had no effect on the enzyme activity under the present assay conditions. We found that 1.3 units of phospholipase A2 were required to lower the protein kinase activity by 60%, presumably by hydrolysing phosphatidylserine to a less effective phospholipid cofactor, lysophosphatidylserine (B. C. Wise, N. Katoh & J. F. Kuo, unpublished work).
Melittin also inhibited cardiac myosin light-chain kinase without affecting its basal activity, with a 50% inhibition similarly seen at about 4#M (Fig. lb) ; phospholipase A2 (up to 10 units/0.2 ml) was without effect on the enzyme (results not shown).
Phospholipid-sensitive Ca2+-dependent protein kinase from different sources (bovine heart, rat brain, pig spleen and human neutrophils) and different states of purity, and the partially purified bovine heart myosin light-chain kinase, were all 1982 lMelittini (#M) Fig. 1 . Inhibition of two species of Ca2+-dependent protein kinases, both from the bovine heart, by two preparations of melittin The assay conditions for the enzymes were as described in the Experimental section, in the presence of various concentrations of melittin, as indicated. (a) Phospholipid-sensitive Ca2+-dependent protein kinase (0.02,g) was incubated in the presence of phosphatidylserine (5,ug/0.2 ml), with (0, A) or without (0, A) CaCl2 (0.1 mM), using a commercial ( ) or pure (----) preparation of melittin. (b) Myosin light-chain kinase (1.4,ug) was incubated in the presence of calmodulin (2,ug/0.2ml, or 0.56pM), with (0) or without (0) CaCl2 (0.1 mM), using a commercial melittin. The commercial preparation of melittin (Sigma Chemical Co.) was employed in all subsequent experiments reported in the present paper. Various kinds and amounts of protein kinases from different sources were incubated in the presence or absence of melittin (15,UM), CaCl2 (500,UM for phospholipid-sensitive Ca2+-dependent enzyme and 100,UM for myosin light-chain kinase), cyclic AMP (0.5,uM) or cyclic GMP (0.5,pM), as indicated. Other assay conditions were as indicated in the legend to Fig. 1 bovine heart (0.01lug) * Leukaphoresed blood was obtained from healthy human volunteers. The neutrophils were further purified by hypoosmotic lysis of the erythrocytes as previously described (Himmelhoch et al., 1969) followed by centrifugation over lymphocyte-separation medium (Bionetics Laboratory Products, Kensington, MD, U.S.A.). The resulting preparation of cells, containing >90% neutrophils, was treated with di-isopropyl fluorophosphate (5mM) as previously described (Amrein & Stossel, 1980) , and washed twice with Hanks balanced salt solution. The cells were then sonicated in 5 vol. of buffer containing 50mM-Tris/HCl (pH7.5), 50mM-2-mercaptoethanol, 1mM-phenylmethanesulphonyl fluoride, 2mM-EGTA, and 0.3% Triton X-100. The sonicated material was gently stirred for lh at 40C and then centrifuged at 1 00000g for 1 h. The resulting supernatant was used as the source of enzyme.
Vol. 202 219 (b) (a) similarly and totally inhibited by melittin at 15 uM (Table 1) , the same as that seen for inhibition of the essentially homogeneous cardiac enzymes shown in Fig. 1 . These findings clearly suggested the lack of specificity of the melittin effect on the phospholipid-sensitive enzyme from different tissues and species. It should be noted here that the activity of the enzyme in the human neutrophils was at least as high as that in the rat brain and spleen, tissues previously shown to be the richest sources of the . In comparison, melittin had little or no effect on the partially purified bovine heart cyclic AMP-dependent protein kinase, the homogeneous preparation of its catalytic subunit, or the partially purified cyclic GMP-dependent protein kinase (Table 1 ). The possibility that the lack of melittin inhibition of the holoenzymes of cyclic nucleotide-dependent protein kinases may be due to the presence of melittin-binding substances in these impure enzyme preparations seemed to be excluded, because the ability of melittin to inhibit Ca2+-dependent enzymes was not affected by the presence of the impure cyclic nucleotide-dependent enzymes (results not shown).
Kinetic analysis revealed that melittin inhibited both the phospholipid-sensitive Ca2+-dependent enzyme ( Fig. 2a) (Fig. 3a) , whereas that of myosin light-chain kinase appeared to be overcome by myosin light chains (Fig. 3b) .
Additional kinetic studies were carried out to elucidate how the melittin inhibition is related to the cofactors (phosphatidylserine and calmodulin) and the activator (Ca2+) of the enzymes. Melittin was Vol. 202 found to totally inhibit the phospholipid-sensitive enzyme in the presence of low phosphatidylserine concentrations, and this inhibition was reversed by high concentrations of the phospholipid (Fig. 4a) . These observations suggest hydrophobic interactions exist between melittin and phosphatidylserine, which may account for the failure of melittin inhibition to obey the classical kinetics noted under the experimental conditions. In contrast, melittin inhibited myosin light-chain kinase competitively with calmodulin, with an average K1 of 0.08pM (Fig.  4b) . Inhibition of the phospholipid-sensitive enzyme by melittin, in contrast with its reversal by phosphatidylserine seen earlier in Fig. 4(a) , was not reversed by increasing Ca2+ concentrations (Fig.  5a ). This inhibition again failed to obey classical kinetics. Melittin, however, was found to inhibit myosin light-chain kinase non-competitively with respect to Ca2 , with an average K1 of 1.9puM (Fig.   5b) .
Discussion
The present studies demonstrated that melittin inhibited the Ca2+-dependent class of protein kinases without affecting appreciably the cyclic nucleotide-dependent class of protein kinases. This specific action of melittin appears to indicate the presence in Ca2+-dependent protein kinases of certain loci that can interact with the surface-active polypeptide, and that these loci appear to be lacking in cyclic nucleotide-dependent enzymes. Functional importance of hydrophobic regions in enzymes stimulated by calmodulin/Ca2+ (such as myosin light-chain kinase in the present studies) has been suggested (Klee et al., 1980; Weiss & Wallace, 1980) . Although the molecular structure of phospholipid-sensitive species of Ca2+-dependent protein kinase has yet to be determined, it is likely that a hydrophobic region is also functionally crucial for the enzyme. This notion is based on the following observations. (1) Phosphatidylserine is essential for supporting the Ca2+-dependent activity of the enzyme (Takai et al., 1979; Kuo et al., 1980) . (2 (Katoh et al., 198 la) and palmitoylcarnitine (Katoh et al., 1981b ) also inhibit the phospholipid-sensitive Ca2+-dependent phosphorylation of histone or endogenous proteins from the heart. It is noteworthy that these two compounds, like melittin, are essentially without effect on cyclic nucleotide-dependent protein kinases (Katoh etal., 1981a,b) .
The effects of melittin on intact cells have often been attributed to the accumulation of lysophospholipids. However, Fain et al. (1981) and Gelehrter & Rozengurt (1980) Kinetic analysis suggests that melittin exerted its action on myosin light-chain kinase by interfering with the formation of the active enzyme-calmodulin-Ca2+ ternary complex, the site of melittin binding on the enzyme being the same as, or proximal to, the calmodulin-binding site. This tentative conclusion was supported by the observations that (1) melittin had little or no effect on the basal activity of the enzyme seen in the absence of added calmodulin and Ca2+ (Fig. Ib) and (2) it non-competitively inhibited the enzyme with respect to ATP (Fig. 2b) or Ca2+ (Fig. 5b) , but competitively inhibited it with respect to calmodulin (Fig.  4b) . The site of interaction of melittin on phospholipid-sensitive Ca2+-dependent enzyme, on the other hand, could not be determined kinetically, because this lytic polypeptide could potentially interact with enzyme, phospholipid cofactor, substrate protein and/or complexes. It seems clear, however, that melittin was not interacting with the free enzyme, since it was without effect on the basal activity of the enzyme (Fig. la) . Melittin and phospholipase A2 are the two major toxins of bee venom (Habermann, 1972 Wise et al., 1981; Katoh et al., 198 lb) . It is possible that the hydrophilic (positively charged) part, instead of, or in addition to, the hydrophobic part, of melittin might be involved in its action; this possibility, although unlikely, cannot be eliminated at present. Several chemically unrelated substances, in addition to melittin, have been shown to inhibit, with comparable potencies, both the calmodulin-sensitive Ca2+-dependent enzymes (e.g. myosin light-chain kinases and certain cyclic nucleotide phosphodiesterases) and phospholipid-sensitive Ca2+-dependent protein kinase. Phenothiazine antipsychotic drugs, such as trifluoperazine and chlorpromazine, reported previously to inhibit calmodulin-sensitive enzymes by interacting with calmodulin-Ca2+ complex (for a review, see Weiss & Wallace, 1980) , also inhibit the phospholipid-sensitive Ca2+-dependent phosphorylation of histone (Mori et al., 1980; Schatzman et al., 1981) and endogenous proteins from the brain . [N-(6-aminohexyl)-5-chloronaphthalene-1-sulphonamidel, shown previously to be an inhibitor of calmodulin-sensitive enzymes , also inhibits the phospholipid-sensitive enzyme (B. C. Wise & J. F. Kuo, unpublished work). In addition, we recently reported that palmitoylcarnitine (Katoh et al., 1981b) and adriamycin (Katoh et al., 1981a) inhibit Ca2+-dependent phosphorylation of histone or cardiac proteins specifically stimulated by calmodulin or phospholipid. These observations, taken collectively, seem to hint at some common features for the calmodulin-sensitive and phospholipid-sensitive Ca2+-dependent enzymes regarding their activation by respective cofactors and inhibition by a diversity of substances. It is worth noting here that, in the light of the abovementioned findings, it is erroneous to assume that phenothazines or compound W-7 block exclusively, primarily or preferentially the calmodulin/Ca2+-stimulated eniyme systems or biological processes. This is particularly true in certain tissues (such as brain and spleen) where the newly recognized phospholipid-sensitive Ca2+-dependent protein kinase is exceptionally abundant .
